The SARS-CoV-2 is a type of coronavirus that has caused the pandemic known as the Coronavirus Disease of 2019, or COVID-19. In traditional epidemiological models such as SEIR (Susceptible, Exposed, Infected, Removed), the exposed group E does not infect the susceptible group S . A distinguishing feature of COVID-19 is that, unlike with previous viral diseases, there is a distinct “asymptomatic” group A , which does not show any symptoms, but can nevertheless infect others, at the same rate as infected symptomatic patients. This situation is captured in a model known as SAIR (Susceptible, Asymptomatic, Infected, Removed), introduced in Robinson and Stillianakis (2013). The dynamical behavior of the SAIR model is quite different from that of the SEIR model. In this paper, we use Lyapunov theory to establish the global asymptotic stabililty of the SAIR model, both without and with vital dynamics. Then we develop compartmental SAIR models to cater to the migration of population across geographic regions, and once again establish global asymptotic stability. Next, we go beyond long-term asymptotic analysis and present methods for estimating the parameters in the SAIR model. We apply these estimation methods to data from several countries including India, and demonstrate that the predicted trajectories of the disease closely match actual data. We show that “herd immunity” (defined as the time when the number of infected persons is maximum) can be achieved when the total of infected, symptomatic and asymptomatic persons is as low as 25% of the population. Previous estimates are typically 50% or higher. We also conclude that “lockdown” as a way of greatly reducing inter-personal contact has been very effective in checking the progress of the disease.

Current epidemiological models can in principle model the temporal evolution of a pandemic. However, any such model will rely on parameters that are unknown, which in practice are estimated using stochastic and poorly measured quantities. As a result, an early prediction of the long-term evolution of a pandemic will quickly lose relevance, while a late model will be too late to be useful for disaster management. Unless a model is designed to be adaptive, it is bound either to lose relevance over time, or lose trust and thus not have a second-chance for retraining. We propose a strategy for estimating the number of infections and the number of deaths, that does away with time-series modeling, and instead makes use of a "phase portrait approach." We demonstrate that, with this approach, there is a universality to the evolution of the disease across countries, that can then be used 1 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) : medRxiv preprint to make reliable predictions. These same models can also be used to plan the requirements for critical resources during the pandemic. The approach is designed for simplicity of interpretation, and adaptivity over time. Using our model, we predict the number of infections and deaths in Italy and New York State, based on an adaptive algorithm which uses early available data, and show that our predictions closely match the actual outcomes.We also carry out a similar exercise for India, where in addition to projecting the number of infections and deaths, we also project the expected range of critical resource requirements for hospitalizations in a location.

A quantitative COVID-19 model that incorporates hidden asymptomatic patients is developed, and an analytic solution in parametric form is given. The model incorporates the impact of lock-down and resulting spatial migration of population due to announcement of lock-down. A method is presented for estimating the model parameters from real-world data, and it is shown that the various phases in the observed epidemiological data are captured well. It is shown that increase of infections slows down and herd immunity is achieved when active symptomatic patients are 10-25% of the population for the four countries we studied. Finally, a method for estimating the number of asymptomatic patients, who have been the key hidden link in the spread of the infections, is presented.

No abstract

No abstract